Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Roundup Lawsuit Filed Over New Diagnosis of NHL, Following Years of Exposure to the Weedkiller Bayer and Monsanto face more than 120,000 claims over Roundup exposure nationwide. February 28, 2022 Irvin Jackson Add Your Comments Nearly two years after Bayer began a settlement process that will see more than $10 billion paid to resolve tens of thousands of Roundup lawsuits, new complaints continue to be filed by individuals recently diagnosed with non-Hodgkins lymphoma following prior use of the controversial weedkiller. On February 23, Dawn Callais filed a complaint (PDF) in the U.S. District Court for the Eastern District of Louisiana against Bayer’s Monsanto subsidiary, indicating that she was diagnosed with non-Hodgkins lymphoma from Roundup in 2021. The case is one of more than 120,000 lawsuits that have been brought in recent years, but a steady stream of new complaints continue to be filed as non-Hodgkins lymphoma continues to be diagnosed among former users who were not adequately warned about the cancer risks associated with the glyphosate-based herbicide. ROUNDUP LAWSUITS Were you or a loved one exposed to RoundUp? Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated. Learn More SEE IF YOU QUALIFY FOR COMPENSATION ROUNDUP LAWSUITS Were you or a loved one exposed to RoundUp? Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Callais indicates that she was exposed to Roundup beginning in 2010, and continued to use the weedkiller through at least 2020. However, she was never warned that exposure could increase the risk of non-Hodgkins lymphoma, which was diagnosed just last year. “Plaintiff maintains that Roundup and/or glyphosate is defective, dangerous to human health, unfit and unsuitable to be marketed and sold in commerce and lacked proper warnings and directions as to the dangers associated with its use,” the lawsuit states. “Plaintiff’s injuries, like those striking thousands of similarly situated victims across the country, were avoidable.” Roundup Settlements Following a string of massive losses in cases that went to trial in 2018 and 2019, Bayer engaged in efforts to settle the Roundup litigation, and indicated last year that it would pay more than $11.6 billion to resolve pending claims. However, finalization of the settlements has been slow and in December, Bayer indicated it was halting settlement talks while it waited to hear whether the U.S. Supreme Court would review the litigation. Bayer’s writ of certiorari asks the Supreme Court to overturn a decision by the Ninth Circuit Court of Appeals, which upheld a $25 million verdict in a case brought by Edwin Hardeman, who developed cancer after spraying Roundup around his home for decades. The company hopes a favorable decision by the U.S. Supreme Court will not only negate that verdict, but will prevent other claims from moving forward. Settlements to resolve Roundup lawsuits began about a year before Callais was diagnosed with non-Hodgkins lymphoma, and Bayer has since announced that it will remove the active ingredient glyphosate from Roundup weed killers sold to U.S. residential customers by 2023. The products would still be sold under the Roundup label, but would use a different active ingredient, which has not been linked to a risk of non-Hodgkin’s lymphoma. Bayer has noted the vast majority of Roundup cancer claims have come from U.S. residential users. However, the company is still expected to face years, if not decades, of future litigation and trials, as prior users develop non-Hodgkin’s lymphoma after exposure to the product during the decades it has been on the market without any cancer warnings. Tags: Bayer, Glyphosate, Herbicide, Monsanto, Non-Hodgkins Lymphoma, Roundup, Weed Killer Image Credit: Photo Courtesy of <a href="https://www.flickr.com/photos/jeepersmedia/14874003257/in/photolist-oEn9Y2-oEmvHy-bTWHFx-nfCdLV-r4HEKx-rnWS2S-r6sFqE-p2qQKx-oZp21Q-p2arLx-oZoYWu-p2qRNe-oZp1K9-oWzFf8-oJWeBo-oWPq8C-p2oWDC-oJWGji-oEmb2Z-oWRdiz-GJW4pR-GGDZ27-a9RCv2-qrg4mF-rnV1kP-fwZmz-2sscR9-oe3oMa-sboouE-7Q9sz-auohod-rbkbaM-dykaWR-HadKLC-rnUQ6F-r4HT7B-rkKbUm-qr3DSm-qr3t6G-r6sNDC-qr3A3h-9Kvo44-5XtM3N-ey91rF-oe3ovi-8XXkwu-odYLgh-nWy2oy-ofPpbP-odSXiw">Mike Mozart via Flickr</a> Creative Commons More Roundup Lawsuit Stories New Study Appears To Confirm Link Between Roundup and Cancer July 7, 2025 U.S. Supreme Court Invites Government To Weigh In on Roundup Cancer Lawsuits July 1, 2025 Roundup Lawsuit Payout of $611M Upheld by Appeals Court May 29, 2025 4 Comments ROMEIL August 15, 2022 I used Roundup for yardwork on a regular basis before being diagnosed with cancer Non Hodgkins Lynfoma in 2020 ROMEIL July 20, 2022 I used Roundup for yardwork on a regular basis before being diagnosed with cancer Non Hodgkins Lynfoma in 2020. ROMEIL July 18, 2022 I used Roundup for yardwork on a regular basis before being diagnosed with cancer Non Hodgkins Lynfoma in 2020. ROMEIL July 17, 2022 I used Roundup for yardwork on a regular basis before being diagnosed with cancer Non Hodgkins Lynfoma in 2020 Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: yesterday) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025) Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: 2 days ago) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025) Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: 2 days ago) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)
Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: yesterday) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025)
Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: 2 days ago) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)
Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: 2 days ago) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)